secwatch.observer — SEC 8-K summary
======================================

Issuer:     CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK:        0001369568
Form:       8-K
Filed at:   2025-05-23T23:59:59+00:00
Accession:  0001193125-25-125872
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Catalyst Pharmaceuticals announces board election results and director O'Keeffe retirement at annual meeting
--------------------------------------------------------------------------------

- Richard J. Daly, McEnany, Denkhaus, Harper, Thompson, Tierney elected to board; O'Keeffe retired after 20+ years, no disagreement.
- Shareholders approved amendment to 2018 Stock Incentive Plan (85.4M for, 4.0M against).
- Advisory vote on 2024 executive compensation passed (82.7M for, 6.5M against).
- Grant Thornton LLP ratified as independent auditor for FY2025 (99.9M for, 1.2M against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369568/000119312525125872/0001193125-25-125872-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369568/000119312525125872/d940123d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-125872

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer